Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical company headquartered at Mumbai, India. Glenmark is the leader in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). The company has a significant presence in branded generics markets across emerging economies including India. It also has a fast growing and robust US generics business. Its stock is listed on India’s two large stock exchanges, the• Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). Glenmark employs nearly 6000 people across its global operations across 80 countries.